Celldex Therapeutics, Inc.
CLDX
Health Care
2
exclusion reasons
1 theme
Celldex Therapeutics, Inc. is screened out under 2 exclusion reasons spanning 1 issue category.
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. It is a statement of values.
Celldex Therapeutics is a clinical-stage biotechnology company whose core business model involves the development of novel antibody-based therapeutics. This research and development process is fundamentally dependent on animal testing. The company conducts extensive pre-clinical studies on animals to assess the safety, efficacy, and pharmacokinetics of its drug candidates before they can proceed to human clinical trials. This use of animals is not incidental but a central, required component of its product development pipeline for treatments targeting cancer and inflammatory diseases.
Celldex Therapeutics is a clinical-stage biotechnology company developing antibody-based therapeutics for cancer and inflammatory diseases. Its drug candidates require preclinical animal testing as part of the FDA-mandated development pathway to assess safety and efficacy before human trials. The company's pipeline, including candidates like barzolvolimab for chronic urticaria and CDX-1140 for various cancers, advances through stages of preclinical and clinical testing that inherently involve animal studies. Celldex is listed by Cruelty Free Investors as a company that conducts pre-clinical studies of its drugs on animals. As a pharmaceutical developer, its core research and development activities are contingent on animal testing to meet regulatory requirements for investigational new drug applications.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.